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Peripheral nerve blocks (PNBs) using local anesthetic (LA) are superior to systemic
analgesia for management of post-operative pain. An insufficiently short PNB duration
following single-shot LA can be optimized by development of extended release
formulations among which liposomes have been shown to be the least toxic. In vivo
rodent models for PNB have focused primarily on assessing behavioral responses
following LA. In a previous study in human volunteers, we found that it is feasible to
monitor the effect of LA in vivo by combining conventional conduction studies with
nerve excitability studies. Here, we aimed to develop a mouse model where the same
neurophysiological techniques can be used to investigate liposomal formulations of
LA in vivo. To challenge the validity of the model, we tested the motor PNB following
an unilamellar liposomal formulation, filled with the intermediate-duration LA lidocaine.
Experiments were carried out in adult transgenic mice with fluorescent axons and
with fluorescent tagged liposomes to allow in vivo imaging by probe-based confocal
laser endomicroscopy. Recovery of conduction following LA injection at the ankle was
monitored by stimulation of the tibial nerve fibers at the sciatic notch and recording of
the plantar compound motor action potential (CMAP). We detected a delayed recovery
in CMAP amplitude following liposomal lidocaine, without detrimental systemic effects.
Furthermore, CMAP threshold-tracking studies of the distal tibial nerve showed that the
increased rheobase was associated with a sequence of excitability changes similar to
those found following non-encapsulated lidocaine PNB in humans, further supporting
the translational value of the model.
Keywords: liposomes, peripheral nerve block, threshold-tracking, in vivo imaging, lidocaine
INTRODUCTION
Adequate pain management has been shown to improve the rate and quality of patient recovery
following surgery (Zaslansky et al., 2015). Peripheral nerve blocks (PNBs) using local anesthetic
(LA) are superior to opioid analgesia which have a high rate of undesirable systemic effects (Wu and
Raja, 2011; Aguirre et al., 2012). Voltage-gated Na+ channel (VGSC) blockers acting as LA (e.g.,
Frontiers in Neuroscience | www.frontiersin.org 1 July 2018 | Volume 12 | Article 494
fnins-12-00494 July 25, 2018 Time: 17:15 # 2
Moldovan et al. In Vivo Local Anesthetic Model
bupivacaine, lidocaine, etc.) are the most widely used drugs in
PNBs. Single PNB only lasts several hours (Wu and Raja, 2011).
Catheter-based PNBs using LA infusions can extend analgesia
(Madsen et al., 2018); however, their efficiency is limited by
mechanical factors and can expose patients to large quantities of
LA (Ilfeld, 2017). Alternatively, several LA carriers with extended
release have been developed, among which liposomes have been
shown to be the least toxic (Weiniger et al., 2012). A multilamellar
liposome formulation of bupivacaine (Exparel) has so far failed
to show PNB of major nerves (Hadzic et al., 2016) and remains
of limited indication (Vyas et al., 2016). Further experimental
work is required to understand the in vivo effects of liposomal
LA nanomedicines.
In vivo rodent models for PNB have focused primarily on
assessing behavioral responses following LA such as the motor
performance on an inverted mesh (Leszczynska and Kau, 1992),
the tail flick latency to a thermal stimulus (Grant et al., 1993),
or the vocalization responses to an electrical shock (Grant
et al., 2000). Such sensory-motor behavioral techniques were
successfully used to investigate the protracted effect of liposomal
LA (Epstein-Barash et al., 2009), and nevertheless, the effect
on axonal function remains poorly investigated. In a previous
study in human volunteers, we found that it is feasible to
monitor the effect of LA in vivo by combining conventional
conduction studies with nerve excitability studies by threshold-
tracking (Moldovan et al., 2014). Here, we aimed to develop a
translational mouse model where the same neurophysiological
techniques can be used to investigate liposomal formulations
of LA in vivo. To challenge the validity of the model, we
tested an unilamellar liposomal formulation, consisting of a
single lipid bilayer (Betageri and Parsons, 1992) which has faster
release profile than multilamellar liposomes (Silva et al., 2016).
The liposomes were filled with the LA lidocaine which has a
shorter duration of action than bupivacaine in extended-release
formulations (Huynh et al., 2015).
MATERIALS AND METHODS
Mice, Anesthesia, and Experimental
Design
Investigations in vivo were carried out in adult mice of C57Bl
background (3- to 5-month-old) with axonal expression of the
Yellow Fluorescent Protein (YFP) reporter (homozygote Thy1-
YFP) obtained from the Jackson Laboratory, Bar Harbor, ME,
United States. General anesthesia was ensured using a 1:1 mixture
of Hypnorm/Midazolam (5 mg/ml). A volume of 0.1 ml/10 g
from the mixture was injected subcutaneously for induction, and
then maintained with 50% hourly for up to 4 h as needed.
Using in vivo neurophysiological recordings (Figure 1), we
monitored the recovery of tibial nerve conduction (Figure 2)
and excitability (Figure 3) following injection of the LA.
Slow subcutaneous injection of a volume of 50 µl at the
ankle engulfed the tibial nerve in an easily observable
bubble (Figure 1C) ensuring the reproducibility of the LA
exposure without the need of ultrasound visualization as
in the case of human PNBs (Moldovan et al., 2014). The
monitoring of the systemic toxicity was carried out using
a 1-channel electrocardiogram (ECG) recorded between the
forepaws (Figure 1B) (MP150 with an ECG100C module, Biopac
Systems Inc., United States).
At the completion of the electrophysiological experiments,
the lateral aspect of the leg was exposed for imaging studies
(Figure 4) after which the mice were killed by cervical dislocation.
This study was carried out in accordance with the
recommendations of directive 2010/63/EU of the European
parliament and of the council on the protection of animals used
for scientific purposes. The protocol was approved by the Danish
Animal Experiments Inspectorate.
Electrophysiological Setup
For in vivo electrophysiological investigations, the mice were
placed on a temperature-controlled pad (HB 101/2, LSI Letica)
set to 37◦C (Moldovan and Krarup, 2006). Stimulation and
recording were carried out using percutaneously inserted Pt-
needle electrodes (Moldovan and Krarup, 2006; Wild et al.,
2018). Electrical stimuli generated from a constant current
stimulator (DS4, Digitimer Ltd.) were delivered proximally
to the sciatic nerve at the sciatic notch (Figures 1A,B) and
distal to the tibial nerve at the ankle (Figures 1A,C). The
evoked compound muscle potential (CMAP) of the plantar
muscle was recorded using a bandpass filter of 10 Hz–
6 kHz (Neurolog NL820A amplifier with NL844 Pre-Amplifier,
Digitimer Ltd., United Kingdom). A ground reference electrode
was inserted into the back of the mouse. The near-nerve electrode
placement was carried out ensuring the lowest threshold
current.
The signals were digitized into a PC-based recording and
control system via a multifunction I/O device (PCI-6221,
National Instruments Corporation Ltd., United Kingdom). The
amplitudes of the CMAP evoked from the proximal (Figure 1D)
and distal (Figure 1E) stimulation sites were measured peak-to-
peak (ppA). The CMAP latency was measured to the first take-off
from baseline (Figures 1D,E).
It should be noted that both from the proximal stimulation site
(Figure 1D) as well as from the distal stimulation site (Figure 1E),
the evoked CMAP was followed by a secondary motor response
(“F-wave”) resulting from motoneuronal backfiring following
antidromic activation in humans (Magladery and Mcdougal,
1950) and rodents (Meinck, 1976; Robertson et al., 1993;
Moldovan et al., 2012). Although the F-waves were not
specifically quantified, their presence was considered as an
indication of the functional integrity of the motoneurons and the
alpha-motor fibers.
Nerve Conduction Studies
We have previously established a setup for the continuous
monitoring of tibial nerve conduction by stimulation at the
ankle for up to 4 h (Moldovan and Krarup, 2006; Alvarez
et al., 2008). Nevertheless, overcoming the partial voltage-
gate Na+ channel block by lidocaine could require very large
stimulation currents (Moldovan et al., 2014). Given the small
distances, using such high currents at ankle could cause the
stimulus to” jump” and activate the unanesthetized part of the
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FIGURE 1 | Experimental setup. (A) Tibial nerve fibers were stimulated proximally (PROX) at the sciatic notch of the ilium (sciatic nerve), to assess recovery of
conduction across the local anesthesia (LA) site, and distally (DIST) to assess recovery of tibial nerve excitability. The evoked compound muscle action potential
(CMAP) was recorded from the plantar muscles. (B) Needle electrode placement for PROX stimulation (S−, S+), CMAP recording (R1, R2), ground electrode (GND),
and ECG recording (ECG-R, ECG-L); (C) Needle electrode placement for DIST stimulation (S-, S+), CMAP recording (R1, R2), and the ground electrode (GND). The
detail at right depicts the local anesthetic injection needle (Inj) as well as the bubble engulfing the tibial nerve at the ankle. The baseline CMAP recordings evoked
from the PROX and DIST stimulation sites were depicted in panels (D,E), respectively. The amplitude CMAP was measured peak-to-peak (ppA) and the
corresponding latency (Lat) to the first take-off from baseline. Note that from both stimulation sites, the evoked CMAP was followed by a secondary motor response
(F-wave) resulting from antidromic activation of the motor neuron pool.
tibial nerve. To avoid this potential confounder, we tested the
changes in conduction across the PNB by proximal stimulation
(Figures 1A,B). Stimulation and recording were controlled using
a custom control software developed in MATLAB (version
R2013b, MathWorks Inc., United States). We delivered negative
rectangular stimuli of 1 ms duration at 0.5 Hz and recorded
1000 ms sweeps with a sampling frequency of 125 KHz
allowing synchronized CMAP (Figure 2A) and ECG recordings
(Figure 2C). The amplitudes at proximal stimulation were
averaged over 1-min and expressed, relative to the 1st minute
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FIGURE 2 | Development and recovery of conduction block after injection of the local anesthetic (LA). (A) The plantar compound muscle action potential CMAP
evoked by proximal stimulation at the sciatic notch after non-encapsulated lidocaine (L. HCL) exposure. After 5 ms, the recordings are presented at 10-fold larger
amplitude to facilitate the visualization of F-waves; (B) The relative changes in peak-to-peak CMAP amplitude (ppA) were shown for the non-encapsulated lidocaine
(L. HCl) experiment in (A) versus 2 other different experiments using liposomal lidocaine (L. Lip); (C) ECG traces recorded during exposure to liposomal lidocaine.
Note that the heart rate, measured from the QRS complexes, remained between 8 and 10 s (corresponding to 480–600 beats per minute). The ppA recovery
corresponding to the ECG after 60 min is indicated in blue in panel (B).
prior to injection (Figure 2B). The stimulation current was
set at twofold the current required to obtain a 100% ppA
CMAP and kept constant for the entire duration of the
recording.
Nerve Excitability Studies
The changes in nerve excitability at the PNB site were monitored
by distal stimulation at the ankle (Figures 1A,C) and tracking
changes in the threshold current (Figures 3A,B) required to
evoke a 40% ppA CMAP (Bostock et al., 1998) using QtracS
stimulation software for recording and QtracP software for
analysis (©Institute of Neurology, London, United Kingdom).
We used that same TRONDH multiple excitability protocol
(Kiernan and Bostock, 2000), that we used in our human PNB
study (Moldovan et al., 2014). We have previously adapted
this protocol for use in mice (Moldovan et al., 2009, 2011).
This allowed recording of the full sequence of excitability
measures (Figure 3C) as previously described in detail (Bostock
et al., 1998; Kiernan and Bostock, 2000; Kiernan et al., 2000):
charge–duration relationship to measure the rheobase, threshold
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FIGURE 3 | Recovery of excitability after injection of the local anesthetic (LA). Baseline measurements (PRE) are compared with measurements at 60 min after
liposomal lidocaine (L. Lip) when there was a partial recovery of conduction. (A) Plantar compound motor action potentials (CMAPs) were evoked by distal
stimulation of the tibial nerve at the ankle (within the nerve area exposed to LA). The thick traces indicate the CMAPs closest to 40% of the maximal CMAP
amplitude, referred to as threshold CMAPs; (B) The stimulus-response measurements corresponding to the recordings in (A). The stippled lines indicate the current
required to evoke the threshold CMAP (symbols), referred to as threshold; (C) The multiple measures of nerve excitability by “threshold-tracking” protocol, measuring
the changes in threshold when varying stimulus duration (charge–duration), when conditioning with 100 ms depolarizing (upward) and hyperpolarizing (downward)
currents that were set to 40% of threshold (threshold electrotonus), when conditioning with a range of 200 ms polarizing currents that were stepped from +50% (top)
to –100% (bottom) of threshold (current–threshold relationship) and following a supramaximal conditioning stimulus (recovery cycle). The arrows indicate that
following liposomal lidocaine there was: an increase in the charge–duration slope, a reduction in threshold changes during both depolarizing and hyperpolarizing
threshold electrotonus, a marked increase in the current–threshold slope on depolarization, and an increased in refractoriness of the recovery cycle.
electrotonus to measure accommodation to shifts in depolarizing
and hyperpolarizing membrane potential, current–threshold
relationship to measure input conductance, and the recovery
of excitability following conduction of the action potential to
measure refractoriness.
Imaging Studies
In vivo imaging (Figure 4) was carried out using probe-based
confocal laser endomicroscopy (pCLE) using a Cellvizio single
band, with a 488-nm laser (Mauna Kea Technologies, France)
which allows for the investigation of fluorescent blood vessels and
axons (Wong et al., 2009). The frames were captured via a S-1500
objective (Figure 4A) and exported using the Cellvizio Viewer for
PC (version 1.4.2).
Liposomal LA Formulation
We formed an unilamelar liposomes using the established
methods of freeze drying lipids followed by rehydration in
lidocaine hydrochloride (2% w/v) phosphate-buffered saline.
This solution was pressure extruded through 100 nm filters to
reduce liposome size polydispersity. The liposomes comprised of
hydrogenated soy L-α-phosphatidylcholine (HSPC), cholesterol
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FIGURE 4 | Imaging of the tibial nerve block area by probe-based confocal laser endomicroscopy (pCLE) at 90 min after liposomal lidocaine (L. Lip). (A) The ankle
was first dissected to allow access of the imaging probe (Probe) to the subcutaneous tissue. Note the scattering of the blue laser light used for imaging; (B)
Superficial veins were fluorescent consistent with the absorption of the fluorescent liposomes. The arrow identifies the same venous confluence in light imaging and
pCLE imaging; (C) With further advancement of the imaging probe between the muscle planes (blunt dissection), the tibial nerve could be readily identified due to its
fluorescent fibers (axonal YFP reporter expression). Occasionally, liposomal accumulations (star) could be identified near the fibers.
(Chol), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
methoxy (polyethylene glycol)-2000 (DSPE-PEG2000), and
1-palmitoyl-2-(dipyrrometheneboron difluoride)undecanoyl-
sn-glycero-3-phosphocholine (TopFluor PC) in a mol% ratio of
54.8:40:5:0.2, respectively. Polyethylene glycol conjugated lipid
was introduced into the liposome bilayer to increase residency
time (Eriksen et al., 2017) and TopFluor PC was incorporated
to allow visualization. The resulting liposome size (Mean ± SD)
was found to be 196.2 ± 2.2 nm with a size polydispersity index
of 0.134 ± 0.03 as determined by dynamic light scattering.
A non-encapsulated lidocaine salt solution (20 mg/ml, L. HCl)
served as control. All chemical components were purchased from
commercial suppliers (Sigma–Aldrich, DE, and Avanti Polar
Lipids, United States).
Frontiers in Neuroscience | www.frontiersin.org 6 July 2018 | Volume 12 | Article 494
fnins-12-00494 July 25, 2018 Time: 17:15 # 7
Moldovan et al. In Vivo Local Anesthetic Model
RESULTS
Recovery of Conduction
Proximal stimulation of the tibial nerve fibers at the sciatic
notch (Figures 1A,B) evoked a CMAP (Mean ± SD) with a
ppA of 12 ± 4 mV and a latency of 1.7 ± 0.1 ms (Figure 1D).
Distal stimulation of the tibial nerve fibers at the ankle
(Figures 1A,C) evoked a CMAP (Mean ± SD) with a ppA
of 16 ± 5 mV and a latency of 1.2 ± 0.1 ms (Figure 1E).
Note that the proximal CMAP was not larger than the
distal CMAP indicating that the CMAP measurements
reflected tibial-nerve innervated muscles with minimal
contamination (if any) from common peroneal nerve innervated
muscles.
An experiment with non-encapsulated lidocaine is detailed
in Figure 2A. Within 3 min following LA injection, there was
a complete abolishment of the CMAP and F-waves evoked
by proximal stimulation which recovered completely within
30 min (Figure 2A). The time-course of CMAP amplitude (ppA)
recovery, measured relative to the minute before LA, is presented
in Figure 2B. In contrast, our model was able to detect a slower
recovery after liposomal lidocaine, with good reproducibility
in repeated studies (Figure 2B). Furthermore, we found that
following liposomal lidocaine the CMAP evoked by proximal
stimulation recovered rapidly to above 50% ppA whereas the
subsequent recovery was much slower (Figure 1B), so that a
full recovery was observed after 3 h (data not shown). Although
liposomes were absorbed, as indicated by pCLE (Figure 4B),
there were no ECG signs of bradycardia (Figure 2C) that could
indicate a confounding effect of lidocaine toxicity.
Recovery of Excitability
During the slow CMAP recovery phase after liposomal lidocaine
(Figure 2B), liposomal accumulations could be demonstrated
by pCLE near the tibial nerve fibers at the ankle (Figure 4C)
suggesting a persistent release. An experiment with uncaged
lidocaine is detailed in Figure 3. We found that during the
partial CMAP recovery phase, evoking the maximal CMAP by
distal stimulation in the nerve exposed to LA required a much
larger stimulation current (Figure 3A) with a right-shift in the
stimulus-response curve (Figure 3B). At that time, the current
required to evoke the CMAP from the proximal stimulation site
remained undistinguishable from the value prior to LA (data not
shown).
To explore the mechanisms of impaired tibial nerve
excitability at the LA site, we carried out multiple measures of
excitability by “threshold-tracking” (Figure 3C). Consistent
with the larger stimulus current required to evoke the
CMAP, we found a marked increase in rheobase (Weiss,
1901; Bostock et al., 1998), as indicated by the slope of the
charge–duration relationship (Figure 3C). Moreover, the
observed increase in rheobase after liposomal lidocaine was
associated with (Figure 3C) a reduction in threshold changes
during both depolarizing and hyperpolarizing threshold
electrotonus, a marked increase in the current–threshold slope
(input conductance) on depolarization, and an increased in
refractoriness of the recovery cycle (Figure 3C).
DISCUSSION
We developed an in vivo mouse model to explore the effect
of local anesthetic nanomedicines on axonal function. We
tested the validity of the model by comparing the effect
of a liposomal lidocaine formulation versus non-encapsulated
lidocaine on motor axon function and found a slower conduction
recovery along the tibial nerve following liposomal lidocaine.
Furthermore, the model opened the possibility to combine
conduction studies with “threshold-tracking” excitability studies
in the same nerve, allowing a translational mechanistic insight
into the liposomal release in vivo.
Assessment of the effect of liposomal local anesthetic
nanomedicines on sciatic nerve block in rodents has been
previously carried out previously by behavioral measures (Yin
et al., 2016). The sensory (thermal nociceptive) blockade was
investigated in a hot-plate paradigm (Sagie and Kohane, 2010),
whereas the motor blockade was investigated using the extensor
postural thrust test (Sagie and Kohane, 2010). Although these
behavioral studies provided a valuable approach to distinguish
the motor versus sensory selectivity of the nanomedicine, they
offered little information on the actual changes in axonal
function. It is long known that the susceptibility to an anesthetic
conduction block is different between neuronal populations,
reflecting differences in membrane properties (Gasser and
Erlanger, 1929). Nevertheless, motor population was found to
be at least as good an indicator for changes in the duration of
PNB as the sensory fibers (Dietz and Jaffe, 1997; Gokin et al.,
2001) even though they do not directly reflect the analgesic
effect. Furthermore, the fact that the myelinated motor axon
population is more functionally homogenous than the sensory
fiber population (Gasser and Erlanger, 1929), can convey an
advantage in characterizing the excitability changes.
The LA lidocaine is thought to impair the function of the
voltage-gated Na+ channels (VGSC) (Sheets and Hanck, 2007)
reducing the axonal “safety factor” for conduction (Tasaki, 1953)
in excitable tissues of the nervous system (Nathan and Sears,
1961) as well as the heart (Austen and Moran, 1965). Although
the pCLE imaging studies indicated liposome accumulation
within veins (Figure 4B), the ECG (Figure 2C) remained within
normal limits (Ho et al., 2011). We therefore do not think that
the observed effects on axonal function were confounded by
lidocaine cardiotoxicity (Fox and Kenmore, 1967).
We confirmed an increase in the threshold for electrical
stimulation during recovery after LA (Gasser and Erlanger, 1929;
Gasser and Grundfest, 1939). Similar deviations in excitability
were found in our previous study using non-encapsulated
lidocaine in humans (Moldovan et al., 2014) which supports
the translational value of our mouse model. These excitability
deviations differed from those observed with selective VGSC
block following accidental tetrodotoxin poisoning in humans
(Kiernan et al., 2005). It is likely that the protracted period of
reduced nerve excitability following LA (Tabatabai and Booth,
1990) reflected both the partial recovery of the Na+ conductance
as well as an impairment of the axolemmal passive electrical
properties (Moldovan et al., 2014) due to a physical effect of
lidocaine dissolved within the membrane (Kassahun et al., 2010).
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In further studies, excitability changes could allow the detection
of early signs of toxicity (Moldovan et al., 2009) in combination
with imaging of morphological changes (Beirowski et al., 2005;
Alvarez et al., 2008, 2013).
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